Your session is about to expire
← Back to Search
Long Peripheral Catheter for Vascular Access Complications (ComPLET Trial)
ComPLET Trial Summary
This trial is testing whether long peripheral catheters (LPCs) are a safer alternative to peripherally inserted central catheters (PICCs) for medium-term vascular access in hospitalized pediatric patients.
ComPLET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowComPLET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ComPLET Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the research protocol exclude participants who are younger than sixty?
"In keeping with the trial's prerequisites, potential participants must be between 2 and 17 years old."
Who fulfills the eligibility criteria for participation in this trial?
"This trial is open to 60 children aged 2-17 who are currently struggling with vascular access device issues. It is a prerequisite for them to have an intravenous treatment that will last between 5 and 14 days, use peripherally compatible infusates, and not require VADs at discharge."
What is the goal of this experiment?
"This study will assess the Average dwell-time over a 12-month period as its primary outcome. Other metrics being observed are the Percent participants with prolonged NPO (nothing by mouth) time, the success rate of VADs for blood draws, number of attempted and successful blood draw attempts through catheterization, and finally, Average time-to-placement of VAD."
To what extent is this trial being participated in by subjects?
"Indeed, the clinicaltrials.gov data confirms that recruitment for this medical study is ongoing. It was launched on August 1st 2022 and amended most recently on August 10th 2022. The trial has a target of 60 patients at one location."
Is enrollment in this research study still open?
"Affirmative. Information available on clinicaltrials.gov indicates that the trial, which was initially posted on August 1st 2022, is actively recruiting patients. Currently, 60 participants are needed at a single medical centre."
Share this study with friends
Copy Link
Messenger